Anders Nelson
Pediatrics · Clarks Summit, PANPI 1457301145
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $494 and has fallen 81.0% since, to $94 in 2025. Among pediatrics clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$292
- Takeda Pharmaceuticals U.S.A., Inc.$292
- GSK$261
- Corium, LLC$241
- Merck$178
- Pfizer$175
- plus $776 from 12 others
What the payments were for
- Food & beverage$2,216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 18 | $292 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $292 |
| GSK | 14 | $261 |
| Corium, LLC | 14 | $241 |
| Merck | 12 | $178 |
| Pfizer | 10 | $175 |
| Aytu Biopharma, Inc. | 9 | $152 |
| Kaleo, Inc. | 11 | $144 |
| Shire North American Group Inc | 10 | $132 |
| Sanofi Pasteur Inc. | 6 | $105 |
| Cranial Technologies, Inc | 3 | $60 |
| Genentech USA, Inc. | 3 | $43 |
| Neurelis, Inc. | 3 | $42 |
| Ironshore Pharmaceuticals Inc. | 3 | $34 |
| Greenwich Biosciences, Inc. | 1 | $21 |
| Neos Therapeutics, LP | 1 | $16 |
| AstraZeneca | 1 | $15 |
| UCB, Inc. | 1 | $11 |
How this compares
$2,216 in reported general payments places this provider in the 95th percentile of 1,849 pediatrics providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 28 | $6,206 |
| Famotidine | 65 | $5,280 |
| Budesonide | 23 | $4,930 |
| Esomeprazole Magnesium | 22 | $4,910 |
| Chlorpromazine Hcl | 15 | $4,265 |
| Clobazam | 15 | $4,233 |
| Levetiracetam | 41 | $3,018 |
| Lorazepam | 29 | $1,509 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 37 | $1,400 |
| Haloperidol Lactate | 28 | $1,351 |
| Carbamazepine | 14 | $1,177 |
| Montelukast Sodium | 39 | $1,146 |
| Fentanyl | 12 | $1,073 |
| Lamotrigine | 27 | $908 |
| Phenobarbital | 12 | $844 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Clarks Summit
- Craig CollisonSpring Mills$670K
- Arthur LeibowitzWynnewood$432K
- Jennifer CorenHatboro$410K
- Todd WolynnPittsburgh$275K
- Mark BlatterPittsburgh$238K
- Hoda Abdel HamidPittsburgh$101K
- Kristopher BossePhiladelphia$90K
- Binita Kamath PatelPhiladelphia$80K
- Kevin StraussGordonville$47K
- Martin BehmHatfield$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.